|
⚲
|
| Keyboard |
| Gayko Urte
✚
|
|
|---|---|
| CIK # | 0001559217 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001559217] | |
| 4 | [0001559217] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Summit Therapeutics Inc | |
| Gayko Urte | |
| Pharmacyclics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2022-04-25 | Grant | 400,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 42,553 | $1.13 | 48,085 |
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2022-01-03 | Grant | 25,000 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2021-11-03 | Grant | 4,041 | ||
|
Summit Therapeutics Inc SMMT
Stock Option (right to buy) · derivative
|
2021-11-03 | Grant | 200,000 | ||
|
Pharmacyclics Inc PCYC
Common Stock
|
2013-04-30 | Other | 406 | $52.24 | 21,209 |
|
Pharmacyclics Inc PCYC
Stock Option (Right to Buy) · derivative
|
2012-10-26 | Grant | 40,000 | $0.00 |